S&P 500
(0.16%) 5 477.90 points
Dow Jones
(0.04%) 39 128 points
Nasdaq
(0.49%) 17 805 points
Oil
(0.06%) $80.88
Gas
(-5.04%) $2.62
Gold
(-0.90%) $2 309.80
Silver
(-0.36%) $28.77
Platinum
(2.90%) $1 015.00
USD/EUR
(0.35%) $0.936
USD/NOK
(0.62%) $10.67
USD/GBP
(0.52%) $0.792
USD/RUB
(0.90%) $88.28

Actualizaciones en tiempo real para POINT Biopharma Global [PNT]

Bolsa: NASDAQ Sector: Healthcare Industria: Biotechnology
Última actualización26 dic 2023 @ 16:00

0.16% $ 12.50

Live Chart Being Loaded With Signals

Commentary (26 dic 2023 @ 16:00):
Profile picture for POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors...

Stats
Volumen de hoy 3.29M
Volumen promedio 3.85M
Capitalización de mercado 1.33B
EPS $-0.230 ( Q3 | 2023-11-13 )
Próxima fecha de ganancias ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 11.36
(Sector) 42.63
(Industry) 24.32
ATR14 $0.322 (2.58%)
AADI -5.88%
ABCL 2.20%
ABCM 0.04%
ABEO -3.08%
ABIO -2.77%
ABOS 0.93%
ABSI 4.42%
ABUS -1.31%
ABVX -2.56%
ACAD -0.64%
ACER -17.95%
ACET -8.84%
ACGN 1.29%
ACHL -2.89%
ACHV 2.59%
ACIU -1.00%
ACLX -0.24%
ACRV -4.29%
ACST -3.58%
ACXP 3.23%
ADAG 7.14%
ADAP -3.97%
ADGI 0.87%
ADIL -3.51%
ADMA -1.54%
ADPT 0.59%
ADTX -3.47%
ADVM 1.01%
ADXN -1.60%
AEON -5.61%
AEZS -2.19%
AFMD -2.62%
AGEN -4.44%
AGIO -2.98%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 7.94%
AKRO -2.43%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -0.92%
ALGS -1.09%
ALKS 1.61%
ALLK -10.17%
ALLO -2.50%
ALLR -3.37%
ALNA 3.16%
ALNY 2.09%
ALPN 0.02%
ALPX 0.00%
ALRN -3.00%
ALT -15.59%
ALVR -1.65%
ALXN 0.00%
ALXO -10.50%
ALZN -1.05%
AMRN -4.13%
AMTI -3.13%
ANAB 1.55%
ANEB 7.20%
ANGN 0.00%
ANIX -4.05%
ANL -0.14%
ANNX 1.53%
ANPC -3.15%
APGE 2.08%
APGN 8.48%
APGNW 30.65%
APLM -6.42%
APLS 0.07%
APLT 0.45%
APM 0.21%
APOP 0.38%
APRE -3.13%
APTO 2.55%
APTX 3.17%
APVO 3.35%
ARAV -13.39%
ARCT -6.81%
ARDS -12.13%
ARDX 1.50%
ARGX -1.26%
ARNA 0.00%
ARPO -0.90%
ARQT -3.23%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.76%
ARWR -2.27%
ASLN -2.23%
ASMB -7.14%
ASND -2.31%
ATAI -3.70%
ATHA 10.05%
ATHE 0.08%
ATHX -33.50%
ATNF 0.99%
ATOS 1.94%
ATRA -6.23%
ATXI 1.94%
ATXS -0.33%
AUPH -1.08%
AURA 4.70%
AUTL -3.45%
AVBP -3.03%
AVEO 0.00%
AVIR -1.75%
AVRO -1.41%
AVTE -0.69%
AVTX -4.26%
AVXL -5.68%
AXLA 0.00%
AXSM -2.39%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.77%
BCAB -7.84%
BCDA -1.02%
BCDAW -46.41%
BCEL 0.00%
BCLI -0.18%
BCRX 1.64%
BCTX 12.76%
BCTXW 11.64%
BCYC 0.95%
BDRX -4.42%
BDTX 0.00%
BEAM 2.43%
BFRA -2.91%
BGNE -3.01%
BIOR -5.65%
BIVI 1.72%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.45%
BLTE -1.65%
BLU 0.03%
BLUE -4.28%
BMEA -14.59%
BMRN 0.33%
BNOX 4.44%
BNTC -5.76%
BNTX -2.20%
BOLD -9.71%
BOLT -1.36%
BPMC -2.47%
BPTH -6.67%
BPTS -13.47%
BRNS -0.37%
BRTX -4.72%
BTAI 11.86%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.48%
CADL 1.06%
CALA 0.00%
CALC -8.27%
CALT -1.87%
CAPR -0.22%
CARA -12.44%
CARM 6.09%
CASI -1.24%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.67%
CCCC -1.70%
CCXI 0.00%
CDAK 0.00%
CDIO -4.74%
CDIOW -28.57%
CDMO -1.27%
CDMOP 0.04%
CDT -13.82%
CDTTW -39.60%
CDTX -6.28%
CDXC 9.43%
CDXS 9.66%
CELC -2.79%
CELU -1.00%
CELUW -15.56%
CERC -1.68%
CERE -1.52%
CERO -4.60%
CEROW -20.36%
CFRX -27.95%
CGEM 0.49%
CGEN -3.31%
CGON -2.90%
CGTX -3.41%
CHMA -6.00%
CHRS 5.06%
CINC 0.00%
CING -3.75%
CINGW 34.95%
CKPT -0.96%
CLBS -16.75%
CLDX -0.28%
CLGN -0.60%
CLLS -3.11%
CLNN -2.47%
CLNNW 0.00%
CLRB 7.04%
CLSD -3.20%
CLSN -0.68%
CLVS 0.00%
CMMB -1.96%
CMND 3.23%
CMPI 0.00%
CMPX 0.00%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.55%
CNCE 0.00%
CNSP -35.21%
CNST 0.00%
CNTA 1.12%
CNTB 0.00%
CNTX -9.59%
COCP -2.40%
COEPW 32.45%
COGT -2.64%
CORT 3.98%
COYA -2.60%
CPRX -0.46%
CRBP -1.94%
CRBU -7.95%
CRDF 3.54%
CRGX -2.01%
CRIS -4.34%
CRNX -5.97%
CRSP 1.22%
CRTX 2.63%
CRVO -7.90%
CRVS 0.56%
CSBR -3.50%
CTCX -11.20%
CTIC 0.06%
CTMX 0.00%
CTNM 4.37%
CTXR -7.15%
CUE -4.50%
CVAC -4.94%
CVKD -1.26%
CWBR 2.80%
CYAD -12.96%
CYCC 19.53%
CYCCP 6.99%
CYCN 7.81%
CYT -2.27%
CYTK -2.12%
CYTO 0.91%
DARE -0.30%
DAWN 0.30%
DBTX -0.81%
DBVT -2.08%
DFFN 10.28%
DICE 0.06%
DMAC 30.97%
DNLI -1.74%
DNTH -2.27%
DOMH -1.06%
DRMA -3.31%
DRMAW -1.25%
DRNA 0.00%
DRTS 2.31%
DRTSW -8.92%
DRUG -0.10%
DSGN -2.42%
DTIL 1.04%
DYAI 9.68%
EARS -1.77%
EDIT -3.22%
EDSA 4.14%
EFTR -3.93%
EFTRW -55.56%
EIGR -9.21%
ELAB -2.41%
ELDN 6.72%
ELEV -2.49%
ELOX 6.15%
ELTX -5.29%
ELVN -1.35%
ELYM 10.04%
ENGN -1.23%
ENGNW -22.50%
ENLV -0.72%
ENOB 1.79%
ENSC 6.53%
ENTA -0.33%
ENTO -4.97%
ENTX 1.60%
ENVB 3.10%
EPIX 2.89%
EPRX -2.87%
EPZM 0.00%
EQ -1.14%
EQRX -2.09%
EQRXW 0.00%
ERAS 5.77%
ERNA -1.11%
ERYP 1.30%
ESLA -1.08%
ESLAW 1.62%
ETNB -7.00%
ETON 2.44%
ETTX 0.00%
EVAX 1.42%
EVGN 2.16%
EVLO 0.00%
EWTX 0.52%
EXAI 0.19%
EXEL 0.54%
EYEG -0.67%
EYEN -3.08%
EYPT -0.85%
FATE -12.37%
FBIO 0.59%
FBIOP 0.87%
FBLG -10.20%
FBRX -0.04%
FDMT -4.50%
FENC -2.90%
FGEN -9.83%
FHTX 5.34%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.72%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.89%
FULC 3.18%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -0.45%
GANX -2.31%
GBIO -1.06%
GBT 0.01%
GDTC 2.03%
GERN -1.55%
GHRS -4.10%
GLMD -2.48%
GLPG -1.91%
GLSI 11.18%
GLTO -3.90%
GLUE -2.64%
GLYC -12.60%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -4.87%
GNPX -3.92%
GNTA 3.94%
GOSS -7.00%
GOVX -8.41%
GOVXW 10.89%
GPCR -5.21%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -3.78%
GRTX 2.19%
GTHX 2.27%
GUTS 0.69%
GXGXW 41.67%
GYRE -5.65%
HALO -0.76%
HARP 0.09%
HCWB -7.15%
HEPA -3.64%
HGEN -84.62%
HILS 5.66%
HLVX 0.08%
HOOK 0.00%
HOTH -2.86%
HOWL 0.00%
HRMY 3.32%
HRTX 9.18%
HSTO 0.00%
HUMA 1.42%
HUMAW -6.25%
IBRX -6.88%
ICCC -0.44%
ICPT 0.21%
ICU 18.87%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.43%
IFRX -1.23%
IGMS -2.05%
IKNA -2.38%
IKT 0.00%
IMAB -0.87%
IMCR -4.15%
IMGN 0.02%
IMGO 0.00%
IMMP 5.32%
IMMX -5.17%
IMNM 4.25%
IMNN -1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.50%
IMTX -1.50%
IMTXW 6.00%
IMUX -9.19%
IMV 0.00%
IMVT -4.51%
INAB -1.80%
INBX -3.11%
INCY -2.14%
INDP 8.72%
INFI -52.38%
INKT 0.00%
INM 0.77%
INMB 1.96%
INO 1.56%
INSM -1.05%
INTS -3.14%
INVA 0.87%
INZY 1.14%
IOBT -7.09%
IONS 1.49%
IOVA -4.02%
IPA 0.50%
IPHA 2.54%
IPSC -3.91%
IRON -2.47%
ISEE 0.38%
ITOS 2.87%
ITRM 1.67%
IVA 6.96%
IVVD 0.00%
JAGX 1.31%
JANX -4.03%
JAZZ -0.85%
JNCE 0.00%
JSPR -1.50%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.96%
KALV -2.08%
KDNY 0.22%
KMPH -0.34%
KNSA -2.32%
KNTE -0.38%
KOD -9.49%
KPRX -4.08%
KPTI -8.71%
KRBP -10.00%
KRON 0.74%
KROS -0.22%
KRRO 0.09%
KRTX 0.03%
KRYS 0.82%
KTRA 9.55%
KTTA -0.65%
KTTAW 82.57%
KURA 0.54%
KYMR -4.04%
KYTX -6.07%
KZIA 4.51%
KZR -3.84%
LABP 0.57%
LBPH 1.57%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.15%
LENZ -3.67%
LEXX 0.77%
LEXXW 23.81%
LGND -1.37%
LGNDV 0.00%
LGVN -9.04%
LIAN -8.28%
LIFE 2.70%
LIPO -9.42%
LIXT -9.81%
LIXTW 45.97%
LJPC -0.32%
LMNL 0.12%
LOGC 0.52%
LPCN -3.68%
LPTX -3.30%
LQDA 0.33%
LRMR -0.21%
LSTA -1.16%
LTRN 6.48%
LUMO 0.67%
LVTX -4.64%
LXEO -13.22%
LXRX -1.18%
LYEL -36.03%
LYRA 3.49%
MACK 0.10%
MBIO -11.26%
MBRX -1.43%
MCRB 0.05%
MDGL -1.67%
MDNA -13.16%
MDWD 4.25%
MDXG -1.77%
MEIP 0.00%
MESO -1.48%
MGNX -5.13%
MGTA -7.74%
MGTX 0.00%
MGX 1.88%
MIRM -0.84%
MIRO 0.59%
MIST 3.08%
MITO 0.00%
MLEC -6.54%
MLECW 3.08%
MLND -5.36%
MLTX 1.23%
MLYS -8.87%
MNKD -0.95%
MNMD 2.83%
MNOV 0.70%
MNPR -9.09%
MOLN 0.76%
MOR 0.45%
MORF -3.16%
MREO -0.29%
MRKR 1.50%
MRNA -11.01%
MRNS -7.35%
MRSN -3.81%
MRTX -0.17%
MRUS 0.37%
MRVI 1.02%
MTCR -1.29%
MTEM 6.93%
MTP -18.50%
MURA -4.95%
MYMD 2.16%
NAMS 0.41%
NAMSW 0.64%
NAUT -1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 10.66%
NCNA -1.45%
NERV -0.32%
NEXI 1.47%
NGM -1.28%
NGNE 2.93%
NKGN 9.24%
NKGNW -20.91%
NKTR 1.40%
NKTX -2.61%
NLSP 7.41%
NLSPW 26.67%
NMRA -1.71%
NMTR -42.97%
NOVN -24.84%
NRBO 13.38%
NRIX -1.63%
NRSN 2.60%
NRSNW 0.00%
NRXP -10.41%
NRXPW 18.33%
NRXS 1.20%
NTBL 2.67%
NTEC -12.45%
NTHI 0.00%
NTLA -4.54%
NTRBW -31.07%
NUVL -1.98%
NVAX -6.36%
NVCT -8.45%
NVIV -34.28%
NXTC -5.88%
NYMX -0.05%
OABI 2.37%
OABIW 2.60%
OBIO 0.15%
OBSV 0.00%
OCEA -3.52%
OCGN 8.47%
OCS 0.25%
OCUL 1.07%
OCUP 0.33%
ODT -4.27%
OKYO 1.72%
OLMA -5.71%
OMER -1.80%
OMGA -2.08%
ONCO 9.93%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 2.97%
ONTX -0.47%
ONVO 1.00%
OPNT 0.00%
OPT -3.09%
ORGS 1.65%
ORIC -1.63%
ORMP 14.73%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.69%
OVID 1.80%
OYST 0.00%
PALI -0.43%
PASG 0.00%
PBLA -7.50%
PBM -3.26%
PBYI 6.08%
PCSA -0.97%
PCVX 0.74%
PDSB -3.80%
PEPG 0.89%
PGEN -7.19%
PHAR 1.99%
PHAS 0.00%
PHAT -1.06%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.55%
PHXM -5.20%
PIRS 0.11%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -3.11%
PLUR 10.43%
PMN -5.55%
PMVP -1.19%
PNT 0.16%
PPBT 2.13%
PRAX 6.33%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 1.79%
PRQR -0.60%
PRTA -3.90%
PRTC -2.46%
PRTG 0.09%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.37%
PSTX -4.26%
PTCT -0.37%
PTE -0.82%
PTGX 0.16%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.90%
QLGN -7.17%
QNCX 2.04%
QNRX -1.34%
QSI -28.31%
QSIAW -9.50%
QTTB 4.94%
QURE -1.35%
RAIN -1.63%
RANI 4.01%
RAPT -0.97%
RARE 1.71%
RCKT -10.73%
REGN -0.19%
RENB -2.48%
REPL -1.25%
RETA 0.02%
REUN -0.89%
REVB -7.44%
REVBU 3.46%
REVBW 4.38%
RGLS -4.67%
RGNX -6.57%
RIGL -6.24%
RLAY -7.12%
RLMD 0.00%
RLYB -6.04%
RNA 2.46%
RNAC 2.87%
RNAZ -0.96%
RNXT 0.89%
ROIV -2.40%
ROIVW 4.56%
RPHM -2.48%
RPRX -1.19%
RPTX -1.17%
RUBY 2.70%
RVLP -32.05%
RVMD -1.06%
RVMDW -30.00%
RVNC -0.43%
RVPH -0.79%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.61%
RYTM -6.74%
RYZB 0.02%
RZLT 3.36%
SABS -3.41%
SABSW -5.53%
SAGE -0.55%
SANA -3.14%
SAVA -3.78%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.56%
SCPH 12.12%
SCPS 0.00%
SEEL -2.79%
SEER -1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -5.19%
SGMT -4.83%
SGTX -2.56%
SIOX 22.63%
SLDB -1.72%
SLGL 5.23%
SLN -8.22%
SLNO 1.59%
SLRX 0.40%
SLS -4.27%
SMMT -3.00%
SNDX 1.74%
SNGX 3.02%
SNPX -2.77%
SONN 0.20%
SPPI -0.49%
SPRB -1.64%
SPRC -2.99%
SPRO 0.00%
SRNE 0.00%
SRPT -0.73%
SRRA 0.00%
SRRK -2.85%
SRZN 6.13%
STAB 0.00%
STOK -7.38%
STRO -1.84%
STSA 0.00%
STTK 6.61%
SURF -0.93%
SVRA 1.05%
SWTX -0.49%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -6.90%
TARS -2.13%
TBPH 0.12%
TCBP 8.77%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT -1.21%
TCRX -1.29%
TECH -1.33%
TENX -0.32%
TERN -8.00%
TFFP -12.18%
TGTX -7.61%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.41%
TNGX -4.21%
TNXP -10.00%
TNYA -4.73%
TPST 4.85%
TRDA -4.54%
TRVI 1.53%
TRVN 2.74%
TSHA -17.24%
TSVT -4.26%
TTNP -6.21%
TVTX 3.64%
TYRA -6.95%
UBX -2.13%
UNCY -4.00%
URGN 4.18%
UTHR -0.03%
VACC 11.36%
VALN -3.15%
VAXX 113.13%
VBIV -0.78%
VBLT -8.77%
VCEL 1.94%
VCNX 5.26%
VCYT -1.01%
VERA -4.29%
VERU 0.54%
VERV -4.02%
VIGL 1.61%
VINC 2.81%
VIR -1.30%
VIRI -4.25%
VIRX -1.75%
VKTX -0.86%
VLON -13.04%
VNDA -2.61%
VOR -7.26%
VRCA 0.14%
VRDN -3.53%
VRNA -2.33%
VRPX -0.48%
VRTX 0.04%
VSTM 4.42%
VTGN -2.11%
VTVT -0.18%
VTYX -2.93%
VXRT -2.09%
VYGR -0.26%
VYNE -7.51%
VYNT 7.78%
WINT -2.72%
WVE -8.28%
XBIO 1.03%
XBIT 1.88%
XCUR 1.26%
XENE -1.16%
XERS 4.76%
XFOR 4.17%
XLO 1.33%
XLRN 0.00%
XNCR 0.41%
XOMA -7.75%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.97%
ZNTL -0.95%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-12-26 Goodman Jonathan R. Sell 41 872 Common Stock
2023-12-27 Goodman Jonathan R. Sell 35 872 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 000 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 614 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 44 749 Stock Option (Right to Buy)
INSIDER POWER
-79.61
Last 96 transactions
Buy: 3 517 450 | Sell: 10 366 533

Volumen Correlación

Largo: 0.24 (neutral)
Corto: -0.64 (weak negative)
Signal:(35.382) Neutral

POINT Biopharma Global Correlación

10 Correlaciones Más Positivas
LVOX0.847
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

POINT Biopharma Global Correlación - Moneda/Commodity

The country flag 0.64
( weak )
The country flag 0.28
( neutral )
The country flag 0.61
( weak )
The country flag 0.44
( neutral )
The country flag 0.03
( neutral )
The country flag -0.77
( moderate negative )

POINT Biopharma Global Finanzas

Annual 2022
Ingresos: $226.58M
Beneficio Bruto: $226.58M (100.00 %)
EPS: $1.040
FY 2022
Ingresos: $226.58M
Beneficio Bruto: $226.58M (100.00 %)
EPS: $1.040
FY 2021
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-1.181
FY 2020
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.00801

Financial Reports:

No articles found.

POINT Biopharma Global Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

POINT Biopharma Global

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico

Total Execution Time: 2.2459790706635 seconds
Number of API calls: 3
Number of DB calls: 9